Most cited published in 2022
- 382
- 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
- Alec Vahanian, Friedhelm Beyersdorf, Fabien Praz, Milan Milojevic, Stephan Baldus, Johann Bauersachs, Davide Capodanno, Lenard Conradi, Michele De Bonis, Ruggero De Paulis, Victoria Delgado, Nick Freemantle, Martine Gilard, Kristina H. Haugaa, Anders Jeppsson, Peter Jüni, Luc Pierard, Bernard D. Prendergast, J. Rafael Sádaba, Christophe Tribouilloy, Wojtek Wojakowski, ESC/EACTS Scientific Document Group
- Rev Esp Cardiol. 2022;75:524
- 202
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC
- Theresa A. McDonagh, Marco Metra, Marianna Adamo, Roy S. Gardner, Andreas Baumbach, Michael Böhm, Haran Burri, Javed Butler, Jelena Čelutkienė, Ovidiu Chioncel, John G.F. Cleland, Andrew J.S. Coats, Maria G. Crespo-Leiro, Dimitrios Farmakis, Martine Gilard, Stephane Heymans, Arno W. Hoes, Tiny Jaarsma, Ewa A. Jankowska, Mitja Lainscak, Carolyn S.P. Lam, Alexander R. Lyon, John J.V. McMurray, Alexandre Mebazaa, Richard Mindham, Claudio Muneretto, Massimo Francesco Piepoli, Susanna Price, Giuseppe M.C. Rosano, Frank Ruschitzka, Anne Kathrine Skibelund, ESC Scientific Document Group
- Rev Esp Cardiol. 2022;75:523
- 3
- High-density lipoprotein cholesterol: a new marker in heart failure
- Carlos G. Santos-Gallego, Juan Antonio Requena-Ibáñez, Juan José Badimón
- Rev Esp Cardiol. 2022;75:855-7
- 3
- Comments on the 2021 ESC/EACTS guidelines for the management of valvular heart disease
- SEC Working Group for the 2021 ESC/EACTS guidelines for the management of valvular heart disease and SEC Guidelines Committee
- Rev Esp Cardiol. 2022;75:466-71
- 2
- Impact of a cardiology consultation integrated with primary care in the follow-up of patients with chronic heart disease
- Raquel Pimienta González, Elena Pérez Cánovas, Zita Morales Rodríguez, Alejandro Quijada Fumero, Celestino Hernández García, Julio Salvador Hernández Afonso
- Rev Esp Cardiol. 2022;75:612-4
- 2
- Smartwatches and ischemic heart disease. A future possibility?
- Mauro Buelga Suárez, Jesús García Montalvo, Gonzalo Luis Alonso Salinas
- Rev Esp Cardiol. 2022;75:764
- 2
- Fabry cardiomyopathy: parametric mapping adds even more
- Virginia Ruiz Pizarro, Jorge Álvarez Rubio, María Jesús Soleto Roncero, Tomás Ripoll-Vera
- Rev Esp Cardiol. 2022;75:845-7
- 1
- No-reflow phenomenon in STEMI: beyond a good angiographic result
- Rafael Cobas Paz, Berenice Caneiro Queija, Andrés Íñiguez Romo
- Rev Esp Cardiol. 2022;75:706-8
- 1
- Cost-effectiveness of transcatheter aortic valve implants in 2022
- Manuel Martínez-Sellés
- Rev Esp Cardiol. 2022;75:853